Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

[18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy

Jelena Levi, Millie Das, Minal S. Vasanawala, Deepti Behl, Martin Pomper, Patrick M. Forde, Erica Nakajima, James Sayre, Bin Shen, Hilda Cabrera, Niko Del Mar, Michele Gullen, Michele Pierini, Laura Cox, Ojaswita Lokre, Timothy Perk and Hee-Don Chae
Journal of Nuclear Medicine October 2024, jnumed.124.268253; DOI: https://doi.org/10.2967/jnumed.124.268253
Jelena Levi
1CellSight Technologies Inc., San Francisco, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Millie Das
2Department of Medicine, Stanford University, Palo Alto, California;
3Veterans Affairs Palo Alto Health Care System, Palo Alto, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minal S. Vasanawala
2Department of Medicine, Stanford University, Palo Alto, California;
3Veterans Affairs Palo Alto Health Care System, Palo Alto, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepti Behl
4Sutter Medical Center, Sacramento, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Pomper
5Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick M. Forde
5Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erica Nakajima
5Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Sayre
6Department of Radiology, David Geffen School of Medicine at UCLA, UCLA Center for the Health Sciences, Los Angeles, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bin Shen
7Department of Radiology, Stanford University, Palo Alto, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hilda Cabrera
1CellSight Technologies Inc., San Francisco, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niko Del Mar
2Department of Medicine, Stanford University, Palo Alto, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele Gullen
4Sutter Medical Center, Sacramento, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele Pierini
4Sutter Medical Center, Sacramento, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Cox
4Sutter Medical Center, Sacramento, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ojaswita Lokre
8AIQ Solutions, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy Perk
8AIQ Solutions, Madison, Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hee-Don Chae
1CellSight Technologies Inc., San Francisco, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.124.268253
DOI 
https://doi.org/10.2967/jnumed.124.268253
PubMed 
39448270

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 16, 2024
  • Accepted for publication September 25, 2024
  • Published online October 24, 2024.

Article Versions

  • You are currently viewing a previous version of this article (October 24, 2024 - 11:58).
  • View the most recent version of this article
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Jelena Levi1,
  2. Millie Das2,3,
  3. Minal S. Vasanawala2,3,
  4. Deepti Behl4,
  5. Martin Pomper5,
  6. Patrick M. Forde5,
  7. Erica Nakajima5,
  8. James Sayre6,
  9. Bin Shen†,7,
  10. Hilda Cabrera1,
  11. Niko Del Mar2,
  12. Michele Gullen4,
  13. Michele Pierini4,
  14. Laura Cox4,
  15. Ojaswita Lokre8,
  16. Timothy Perk8 and
  17. Hee-Don Chae1
  1. 1CellSight Technologies Inc., San Francisco, California;
  2. 2Department of Medicine, Stanford University, Palo Alto, California;
  3. 3Veterans Affairs Palo Alto Health Care System, Palo Alto, California;
  4. 4Sutter Medical Center, Sacramento, California;
  5. 5Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland;
  6. 6Department of Radiology, David Geffen School of Medicine at UCLA, UCLA Center for the Health Sciences, Los Angeles, California;
  7. 7Department of Radiology, Stanford University, Palo Alto, California; and
  8. 8AIQ Solutions, Madison, Wisconsin
  1. For correspondence or reprints, contact Jelena Levi (jlevi{at}cellsighttech.com).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Editorial: Tumor microenvironment and beyond: imaging systemic immunity with PET
    Jelena Levi, Israt S. Alam, Tomomi W. Nobashi
    Frontiers in Medicine 2024 11

Article usage

Article usage: October 2024 to April 2025

AbstractFullPdf
Oct 202412824033
Nov 20246644429
Dec 202412069944
Jan 202554798
Feb 202532486
Mar 2025229115
Apr 20252272016
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
[18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
[18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
Jelena Levi, Millie Das, Minal S. Vasanawala, Deepti Behl, Martin Pomper, Patrick M. Forde, Erica Nakajima, James Sayre, Bin Shen, Hilda Cabrera, Niko Del Mar, Michele Gullen, Michele Pierini, Laura Cox, Ojaswita Lokre, Timothy Perk, Hee-Don Chae
Journal of Nuclear Medicine Oct 2024, jnumed.124.268253; DOI: 10.2967/jnumed.124.268253

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
[18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy
Jelena Levi, Millie Das, Minal S. Vasanawala, Deepti Behl, Martin Pomper, Patrick M. Forde, Erica Nakajima, James Sayre, Bin Shen, Hilda Cabrera, Niko Del Mar, Michele Gullen, Michele Pierini, Laura Cox, Ojaswita Lokre, Timothy Perk, Hee-Don Chae
Journal of Nuclear Medicine Oct 2024, jnumed.124.268253; DOI: 10.2967/jnumed.124.268253
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • molecular imaging
  • oncology
  • non–small cell lung cancer
  • systemic immunity
SNMMI

© 2025 SNMMI

Powered by HighWire